Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-01 @ 8:35 AM
Study NCT ID:
NCT05029232
Status:
UNKNOWN
Last Update Posted:
2021-08-31
First Post:
2021-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'submissionInfos': [{'resetDate': '2024-07-19', 'releaseDate': '2024-01-17'}], 'estimatedResultsFirstSubmitDate': '2024-01-17'}}, 'conditionBrowseModule': {'meshes': [{'id': 'D020388', 'term': 'Muscular Dystrophy, Duchenne'}], 'ancestors': [{'id': 'D009136', 'term': 'Muscular Dystrophies'}, {'id': 'D020966', 'term': 'Muscular Disorders, Atrophic'}, {'id': 'D009135', 'term': 'Muscular Diseases'}, {'id': 'D009140', 'term': 'Musculoskeletal Diseases'}, {'id': 'D009468', 'term': 'Neuromuscular Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D040181', 'term': 'Genetic Diseases, X-Linked'}, {'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D013960', 'term': 'Thyroid Function Tests'}, {'id': 'D004576', 'term': 'Electromyography'}, {'id': 'D009431', 'term': 'Neural Conduction'}, {'id': 'D004452', 'term': 'Echocardiography'}], 'ancestors': [{'id': 'D003940', 'term': 'Diagnostic Techniques, Endocrine'}, {'id': 'D019937', 'term': 'Diagnostic Techniques and Procedures'}, {'id': 'D003933', 'term': 'Diagnosis'}, {'id': 'D004568', 'term': 'Electrodiagnosis'}, {'id': 'D009213', 'term': 'Myography'}, {'id': 'D055724', 'term': 'Electrophysiological Phenomena'}, {'id': 'D010829', 'term': 'Physiological Phenomena'}, {'id': 'D009424', 'term': 'Nervous System Physiological Phenomena'}, {'id': 'D055687', 'term': 'Musculoskeletal and Neural Physiological Phenomena'}, {'id': 'D057791', 'term': 'Cardiac Imaging Techniques'}, {'id': 'D003952', 'term': 'Diagnostic Imaging'}, {'id': 'D014463', 'term': 'Ultrasonography'}, {'id': 'D006334', 'term': 'Heart Function Tests'}, {'id': 'D003935', 'term': 'Diagnostic Techniques, Cardiovascular'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'SCREENING', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 50}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2021-10-01', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-08', 'completionDateStruct': {'date': '2023-08-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2021-08-29', 'studyFirstSubmitDate': '2021-07-14', 'studyFirstSubmitQcDate': '2021-08-29', 'lastUpdatePostDateStruct': {'date': '2021-08-31', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-08-31', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-02-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'change in dystrophine gene mutation', 'timeFrame': 'within six months', 'description': 'MLPA test'}, {'measure': 'change in MRI findings in DMX patient from normal', 'timeFrame': 'within six months', 'description': 'by MRI brain'}, {'measure': 'change in cardiac function in DMD patient', 'timeFrame': 'within six months', 'description': 'by Echocardiography to detect EF, FS'}, {'measure': 'change in thyroid function in DMD patient', 'timeFrame': 'within six months', 'description': 'by thyroid function test'}, {'measure': 'change in cognitive function in DMD patients', 'timeFrame': 'within six months', 'description': 'by Stanford IQ test'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Duchenne Muscular Dystrophy']}, 'referencesModule': {'references': [{'pmid': '29395989', 'type': 'BACKGROUND', 'citation': 'Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3.'}, {'pmid': '29395990', 'type': 'BACKGROUND', 'citation': 'Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018 Apr;17(4):347-361. doi: 10.1016/S1474-4422(18)30025-5. Epub 2018 Feb 3.'}, {'pmid': '24135430', 'type': 'BACKGROUND', 'citation': 'Giliberto F, Radic CP, Luce L, Ferreiro V, de Brasi C, Szijan I. Symptomatic female carriers of Duchenne muscular dystrophy (DMD): genetic and clinical characterization. J Neurol Sci. 2014 Jan 15;336(1-2):36-41. doi: 10.1016/j.jns.2013.09.036. Epub 2013 Oct 5.'}]}, 'descriptionModule': {'briefSummary': 'Muscular dystrophies are a heterogenous group of inherited muscular disorders characterized by progressive muscle weakness. Historically, these disorders are difficult to treat. In the last three decades, there is a great progress in molecular and genetic basis of these disorders; early diagnosis is achievable with proper clinical recognition and advanced genetic testing .Duchenne Muscular Dystrophy (DMD) is a neuromuscular muscular X-linked recessive disorders that belong to a group of disorders known as dystrophinopathies. DMD characterized by a progressive degeneration of skeletal muscles, with symptoms that manifest early, at around 3 years, causing loss of ambulation within the 13 years of life, followed by cardiac complication (e.g., dilated cardiomyopathy and arrhythmia) and respiratory disorders, including chronic respiratory failure. The unique medical treatment available is steroid therapy, which appears to prolong walking capacity by at least two years. Thus, besides medical treatment, the physical therapy in multidisciplinary care is imperative for alleviating muscle atrophy, skeletal deformities, and motor function deterioration.'}, 'eligibilityModule': {'sex': 'MALE', 'stdAges': ['CHILD', 'ADULT'], 'maximumAge': '18 Years', 'minimumAge': '3 Years', 'genderBased': True, 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. age of onset between 3- and 18-year-old\n2. typical clinical manifestation of Duchenne muscular dystrophy\n3. clinical manifestation confirmed by specific biochemical analysis or by genetic testing who presented to pediatric department and neurology outpatient clinic during the period of study.\n\nExclusion Criteria:\n\n1. children with another congenital muscular dystrophy\n2. children with other types of myopathies\n3. presence of CNS disorders such as brain insult \\& spinal muscular atrophy\n4. female gender'}, 'identificationModule': {'nctId': 'NCT05029232', 'briefTitle': 'Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital', 'organization': {'class': 'OTHER', 'fullName': 'Sohag University'}, 'officialTitle': 'Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital', 'orgStudyIdInfo': {'id': 'Soh-Med-21-07-21'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'ambulant patient with DMD', 'description': 'patient that walk alone or with minor assist', 'interventionNames': ['Diagnostic Test: MLPA for duchenne']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'non ambulant patient with DMD', 'description': 'patient need wheel chair', 'interventionNames': ['Diagnostic Test: MLPA for duchenne']}], 'interventions': [{'name': 'MLPA for duchenne', 'type': 'DIAGNOSTIC_TEST', 'otherNames': ['muscle enzymes', 'thyroid function', 'EMG , nerve conduction for limbs', 'echocardiography , MRI brain , IQ test'], 'description': 'MLPA test for genetic testing to detect gene affection in DMD , and other tests for confirmation and follow up', 'armGroupLabels': ['ambulant patient with DMD', 'non ambulant patient with DMD']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Sohag', 'country': 'Egypt', 'contacts': [{'name': 'Osama R ElSherif, professor', 'role': 'CONTACT'}], 'facility': 'Sohag University Hospital', 'geoPoint': {'lat': 26.55695, 'lon': 31.69478}}], 'centralContacts': [{'name': 'nehal s abdel magoud, assistant lecturer', 'role': 'CONTACT', 'email': 'nehal.abdelmawgoud@med.sohag.edu.eg', 'phone': '01091666230'}, {'name': 'abdel rahim A sadek, professor', 'role': 'CONTACT', 'email': 'abdelreheam_sadek@med.sohag.edu.eg', 'phone': '01065067057'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'YES'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Sohag University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Assistant lecturer of pediatric. sohag university hospitals', 'investigatorFullName': 'Nehal Samy Abdo', 'investigatorAffiliation': 'Sohag University'}}}, 'annotationSection': {'annotationModule': {'unpostedAnnotation': {'unpostedEvents': [{'date': '2024-01-17', 'type': 'RELEASE'}, {'date': '2024-07-19', 'type': 'RESET'}], 'unpostedResponsibleParty': 'Nehal Samy Abdo, Assistant lecturer of pediatric. sohag university hospitals, Sohag University'}}}}